This suggests that factors in addition to DNAH8 regulate AR-mediated gene expression during prostate cancer initiation and progression, and is consistent with multiple AR regulatory factors being identified in our RNAi screen. This evidence concerns the gene DNAH8 and prostate carcinoma.